Financial statements Pharmovit Produkcja
Balance sheet data of PHARMOVIT PRODUKCJA
|
Year
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|
| Total assets | 197 649,52 | 286 340,48 | 387 188,45 | 148 284,66 | 87 535,58 |
| A. Fixed assets | - | - | - | - | - |
| B. Current assets | 197 649,52 | 286 340,48 | 387 188,45 | 148 284,66 | 87 535,58 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 197 649,52 | 286 340,48 | 387 188,45 | 148 284,66 | 87 535,58 |
| A. Equity | 156 648,02 | 270 233,83 | 332 503,29 | 44 077,24 | 81 343,38 |
| B. Liabilities and provisions for liabilities | - | 16 106,65 | 16 106,65 | 104 207,42 | 6 192,20 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.